Skip to content

Research at St Andrews

Perinatal complications in female survivors of cancer: a systematic review and meta-analysis

Research output: Contribution to journalArticlepeer-review

Author(s)

Anne Lotte van der Kooi, Thomas William Kelsey, Marry van den Heuvel-Eibrink, Joop S. E. Laven, W. Hamish B. Wallace, Richard A. Anderson

School/Research organisations

Abstract

Background: Observational studies have suggested that perinatal outcomes are worse in offspring of cancer survivors. We conducted a systematic review and meta-analysis to examine the risks of perinatal complications in female cancer survivors diagnosed before the age of 40 years.

Methods: All published articles on pregnancy, perinatal or congenital risks in female cancer survivors were screened for eligibility. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed.

Results: Twenty-two studies met the inclusion criteria. Meta-analysis indicates that offspring of cancer survivors are at increased risk of prematurity (relative risk [RR]: 1.56; 95% confidence interval [CI] 1.37–1.77) and low birth weight (RR 1.47; 95% CI 1.24–1.73) but not of being small for gestational age (RR 0.99; 95% CI 0.81–1.22). Cancer survivors have higher rates of elective (RR: 1.38; 95% CI 1.13–1.70) and emergency caesarean section (RR: 1.22; 95% CI 1.15–1.30) as well as assisted vaginal delivery (RR: 1.10; 95% CI 1.02–1.18) and are at increased risk of postpartum haemorrhage (RR: 1.18; 95% CI 1.02–1.36). The risk of congenital abnormalities also appears increased (RR 1.10; 95% CI 1.02–1.20), but this is likely to be an artefact of analysis. Although meta-analysis of the effects of radiotherapy was not possible for all outcomes, there was an increased risk of prematurity (RR 2.27; 95% CI 1.34–3.82) and consistent findings of low birth weight (RR 1.38–2.31). Risk of being small for gestational age was increased only after high uterine radiotherapy dosage.

Conclusion: The increased perinatal risks warrant a proactive approach from healthcare providers in both counselling and management of perinatal care for cancer survivors.
Close

Details

Original languageEnglish
Pages (from-to)126-137
JournalEuropean Journal of Cancer
Volume111
Early online date5 Mar 2019
DOIs
Publication statusPublished - Apr 2019

    Research areas

  • Cancer survivors, Perinatal risk, Premature delivery, Postpartum haemorrhage, Low birth weight, Congenital abnormalities

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Repurposing “old” blood tests to replace costly interim analysis/imaging of Hodgkin lymphoma in low and middle-income settings

    Geel, J., Kelsey, T., Hramyka, A., Myezo, K., Hendricks, M., Ngcana, T., Omar, F., Goga, Y., Neethling, B., Netshituni, V., van Zyl, A., Madzhia, E., Mathew, R., Ballot, D. & Metzger, M., 18 Oct 2021, p. PV0473 / #1372.

    Research output: Contribution to conferenceAbstractpeer-review

  2. Performance of plasma kisspeptin as a biomarker for miscarriage improves with gestation during the first trimester

    Abbara, A., Al-Memar, M., Phylactou, M., Kyriacou, C., Eng, P. C., Nadir, R., Izzi-Engbeaya, C., Clarke, S. A., Mills, E. G., Daniels, E., Huo, L., Pacuszka, E., Yang, L., Patel, B., Tan, T., Bech, P., Comninos, A. N., Fourie, H., Kelsey, T., Bourne, T. & 1 others, Dhillo, W. S., Sep 2021, In: Fertility and Sterility. 116, 3, p. 809-819 11 p.

    Research output: Contribution to journalArticlepeer-review

  3. Changes in circulating kisspeptin levels during each trimester in women with antenatal complications

    Abbara, A., Al-Memar, M., Phylactou, M., Daniels, E., Patel, B., Chia Eng, P., Nadir, R., Izzi-Engbeaya, C., Clarke, S., Millis, E., Hunjan, T., Pacuszka, E., Yang, L., Bech, P., Tan, T., Comninos, A., Kelsey, T., Kyriacou, C., Fourie, H., Bourne, T. & 1 others, Dhillo, W., 24 Aug 2021, (E-pub ahead of print) In: Journal of Clinical Endocrinology & Metabolism. Advance Article, 13 p., dgab617.

    Research output: Contribution to journalArticlepeer-review

  4. Clinical and biochemical discriminants between Functional Hypothalamic Amenorrhoea (FHA) and Polycystic Ovary Syndrome (PCOS)

    Phylactou, M., Clarke, S. A., Patel, B., Baggaley, C., Jayasena, C. N., Kelsey, T., Comninos, A. N., Dhillo, W. S. & Abbara, A., Aug 2021, In: Clinical Endocrinology. 95, 2, p. 239-252

    Research output: Contribution to journalReview articlepeer-review

  5. Long-term follow up to assess criteria for ovarian tissue cryopreservation for fertility preservation in young women and girls with cancer

    Howie, R., Duffin, K., Kelsey, T., Wallace, W. H. B. & Anderson, R. A., Jul 2021, In: Human Reproduction. 36, p. 98-98 1 p.

    Research output: Contribution to journalAbstractpeer-review

Related by journal

  1. Do participants in adjuvant breast cancer trials reflect the breast cancer patient population?

    Treweek, S., Dryden, R., McCowan, C., Harrow, A. & Thompson, A., May 2015, In: European Journal of Cancer. 51, 8, p. 907-914

    Research output: Contribution to journalArticlepeer-review

  2. Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway

    Riches, A., Campbell, E., Borger, E. & Powis, S., Mar 2014, In: European Journal of Cancer. 50, 5, p. 1025-34 10 p.

    Research output: Contribution to journalArticlepeer-review

  3. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer

    Anderson, R., Rosendahl, M., Kelsey, T. & Cameron, D., Nov 2013, In: European Journal of Cancer. 49, 16, p. 3404-3411

    Research output: Contribution to journalArticlepeer-review

ID: 257498619

Top